How experienced <scp>ICU</scp> specialists make decisions on prophylactic platelet transfusions—A qualitative study
Most doctors expressed uncertainty about balancing benefits and harm. Platelet transfusions were often used to prevent bleeding despite uncertainty on the effect and were typically triggered by fear of consequences when performing a procedure, which was an important driver. The departmental culture and colleagues' attitudes were far more important influencers on decision-making than guideline recommendations. Most doctors thought it was possible for blood products to transfer unknown and potentially harmful substances to patients, although this did not appear to influence their daily practice.
Authors
- Kathryn A. Puxty (ORCID: https://orcid.org/0000-0002-5742-6171)
- Lene Russell (ORCID: https://orcid.org/0000-0001-7352-8728)
- Joanne McPeake (ORCID: https://orcid.org/0000-0001-8206-6801)
- Nancy Kentish‐Barnes (ORCID: https://orcid.org/0000-0003-0024-0429)
- Élie Azoulay (ORCID: https://orcid.org/0000-0002-8162-1508)
Institutions
- University of Copenhagen (DK)
- Université Paris Cité (FR)
- University of Cambridge (GB)
- Glasgow Royal Infirmary (GB)
- Gentofte Hospital (DK)
- Sorbonne Paris Cité (FR)
- Hôpital Saint-Louis (FR)
Publication Details
- Journal
- Transfusion
- Published
- 2025-05-27
- DOI
- https://doi.org/10.1111/trf.18290
- Citations
- 1
- Primary Topic
- Blood transfusion and management
- Type
- article
- Field-Weighted Citation Impact
- 0.77
Funders
- Pfizer
- AstraZeneca
- Gilead Sciences
- Alexion Pharmaceuticals
- Dagmar Marshalls Fond
- Ablynx